Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth — Jamie Harris (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth
DK
Shared by
David Kaplan
Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth
Article
2016
en
Authors
+2 more
JH
Jamie Harris
JC
Jeannine M. Coburn
AK
Andre Kajdacsy‐Balla
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Concurrent application of interferon-gamma and vincristine inhibits tumor growth in an orthotopic neuroblastoma mouse model
Jasmine Zeki
,
Burçin Yavuz
,
Lauren Wood
,
Hiroyuki Shimada
,
David Kaplan
,
Bill Chiu
Article
2015
Intratumoral Implantation of Vincristine-Loaded Sustained-Release Silk Sponge Is Effective in Tumor Control in an Orthotopic Neuroblastoma Murine Model
Jamie Harris
,
Jeannine M. Coburn
,
Jennifer Poirier
,
David Kaplan
,
Bill Chiu
Article
2013
Surgical resection combined with application of doxorubicin-loaded sustained release silk film as a treatment strategy in an orthotopic xenograft neuroblastoma mouse model
Bill Chiu
,
Jeannine M. Coburn
,
F. Philipp Seib
,
Alain Charest
,
David Kaplan
Article
2019
Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer
Eva Fiegle
,
Dennis Doleschel
,
Susanne Koletnik
,
Anne Rix
,
Ralf Weiskirchen
,
Erawan Borkham‐Kamphorst
,
Fabian Kießling
,
Wiltrud Lederle
Article
2012
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model
Femke Heindryckx
,
Eliene Bogaerts
,
Stéphanie Coulon
,
Hilde Devlies
,
Anja Geerts
,
Louis Libbrecht
,
Jean Marie Stassen
,
Peter Carmeliet
,
Isabelle Colle
,
Hans Van Vlierberghe
Discussion(0)
No comments yet. Be the first to comment.